Literature DB >> 19619796

Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart.

Takaya Hoashi1, Goro Matsumiya, Shigeru Miyagawa, Hajime Ichikawa, Takayoshi Ueno, Masamichi Ono, Atsuhiro Saito, Tatsuya Shimizu, Teruo Okano, Naomasa Kawaguchi, Nariaki Matsuura, Yoshiki Sawa.   

Abstract

OBJECTIVE: The development of right ventricular dysfunction has become a common problem after surgical repair of complex congenital heart disease. A recent study reported that tissue-engineered skeletal myoblast sheet transplantation improves left ventricular function in patients with dilated and ischemic cardiomyopathy. Therefore myoblast sheet transplantation might also improve ventricular performance in a rat model of a pressure-overloaded right ventricle.
METHODS: Seven-week-old male Lewis rats underwent pulmonary artery banding. Four weeks after pulmonary artery banding, myoblast sheet transplantation to the right ventricle was performed in the myoblast sheet transplantation group (n = 20), whereas a sham operation was performed in the sham group (n = 20).
RESULTS: Four weeks after performing the procedure, a hemodynamic assessment with a pressure-volume loop showed a compensatory increase in systolic function in both groups. However, only the myoblast sheet transplantation group showed a significant improvement in the diastolic function: end-diastolic pressure (sham vs myoblast sheet transplantation, 10.3 +/- 3.1 vs 5.0 +/- 3.7 mm Hg; P < .001), time constant of isovolumic relaxation (11.1 +/- 2.5 vs 7.6 +/- 1.2 ms, P < .001), and end-diastolic pressure-volume relationship (16.1 +/- 4.5 vs 7.6 +/- 2.4/mL, P < .005). The right ventricular weight and cell size similarly increased in both groups. A histologic assessment demonstrated significantly suppressed ventricular fibrosis and increased capillary density in the myoblast sheet transplantation group in comparison with those in the sham group. Reverse transcription-polymerase chain reaction demonstrated an increased myocardial gene expression of hepatocyte growth factor and vascular endothelial growth factor in the myoblast sheet transplantation group but not in the sham group.
CONCLUSIONS: Skeletal myoblast sheet transplantation improved the diastolic dysfunction and suppressed ventricular fibrosis with increased capillary density in a rat model of a pressure-overloaded right ventricle. This method might become a novel strategy for the myocardial regeneration of right ventricular failure in patients with congenital heart disease.

Entities:  

Mesh:

Year:  2009        PMID: 19619796     DOI: 10.1016/j.jtcvs.2009.02.018

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  23 in total

1.  Engineered fetal cardiac graft preserves its cardiomyocyte proliferation within postinfarcted myocardium and sustains cardiac function.

Authors:  Kazuro L Fujimoto; Kelly C Clause; Li J Liu; Joseph P Tinney; Shivam Verma; William R Wagner; Bradley B Keller; Kimimasa Tobita
Journal:  Tissue Eng Part A       Date:  2011-01-16       Impact factor: 3.845

2.  Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium.

Authors:  Arlo N McGinn; Hye Yeong Nam; Mei Ou; Norman Hu; Catherine M Straub; James W Yockman; David A Bull; Sung Wan Kim
Journal:  Biomaterials       Date:  2010-11-05       Impact factor: 12.479

3.  Substrate stiffness affects skeletal myoblast differentiation in vitro.

Authors:  Sara Romanazzo; Giancarlo Forte; Mitsuhiro Ebara; Koichiro Uto; Stefania Pagliari; Takao Aoyagi; Enrico Traversa; Akiyoshi Taniguchi
Journal:  Sci Technol Adv Mater       Date:  2012-11-23       Impact factor: 8.090

4.  Myocardial regenerative therapy using a scaffold-free skeletal-muscle-derived cell sheet in patients with dilated cardiomyopathy even under a left ventricular assist device: a safety and feasibility study.

Authors:  Yasushi Yoshikawa; Shigeru Miyagawa; Koichi Toda; Atsuhiro Saito; Yasushi Sakata; Yoshiki Sawa
Journal:  Surg Today       Date:  2017-08-18       Impact factor: 2.549

Review 5.  Stem cell therapies in patients with single ventricle physiology.

Authors:  Suguru Tarui; Shunji Sano; Hidemasa Oh
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Apr-Jun

Review 6.  Stem cell therapy for CHD: towards translation.

Authors:  Brody Wehman; Osama T Siddiqui; Rachana Mishra; Sudhish Sharma; Sunjay Kaushal
Journal:  Cardiol Young       Date:  2015-08       Impact factor: 1.093

Review 7.  Skeletal myoblasts for cardiac repair.

Authors:  Shazia Durrani; Mikhail Konoplyannikov; Muhammad Ashraf; Khawaja Husnain Haider
Journal:  Regen Med       Date:  2010-11       Impact factor: 3.806

Review 8.  Surgical and physiological challenges in the development of left and right heart failure in rat models.

Authors:  Michael G Katz; Anthony S Fargnoli; Sarah M Gubara; Elena Chepurko; Charles R Bridges; Roger J Hajjar
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

9.  The emergence of stem cell therapy for patients with congenital heart disease.

Authors:  Brody Wehman; Sunjay Kaushal
Journal:  Circ Res       Date:  2015-02-13       Impact factor: 17.367

Review 10.  The current status and future of cardiac stem/progenitor cell therapy for congenital heart defects from diabetic pregnancy.

Authors:  Jianxiang Zhong; Shengbing Wang; Wei-Bin Shen; Sunjay Kaushal; Peixin Yang
Journal:  Pediatr Res       Date:  2017-11-15       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.